For joint pain in knee osteoarthritis and in active athletes, a series of randomised studies consistently points in a positive direction for hydrolysed collagen (approximately 10 grams per day), working best in combination with exercise. The evidence is reasonable but not yet strong enough for firm guidelines, and for the skin it is preliminary and partly derived from commercially involved researchers. At the available doses, collagen has been well tolerated with no reported serious side effects.
For joint pain in knee osteoarthritis, a meta-analysis of 11 randomised trials (870 participants) points to a significant beneficial effect of oral hydrolysed collagen on both pain and joint function. The variation between the individual studies was considerable, however, meaning that the outcome was not equally strong across the board. The best-supported regimen is a daily dose of approximately 10 grams for at least 24 weeks.
In people without joint disease as well, such as athletes with knee pain, several double-blind studies show a reduction in joint pain. One RCT with university athletes found improvement across six pain measurement points at 10 grams per day; another study saw this effect only in people who exercise more than three hours per week. A systematic review of 15 studies also concludes that collagen works best in combination with physical exercise, not as a replacement for it.
Two types of collagen are the most studied. Hydrolysed collagen (collagen peptides) provides small building blocks that can reach cartilage via the bloodstream. Native type II collagen is thought to work through an entirely different pathway: it suppresses inflammatory processes in the joint via the immune system. This distinction is scientifically relevant, but the review in question was written by authors affiliated with a collagen manufacturer, so independent confirmation is desirable.
For the skin, the indications are more preliminary. Laboratory studies show that hydrolysed collagen can stimulate the production of skin collagen and hyaluronic acid, and smaller clinical studies suggest a reduction in visible signs of ageing. Here too, however, the available review in this area comes from authors with a commercial interest, making independent confirmation necessary. The skin claims are therefore less well supported than the joint claims.
On safety, the picture is reasonably reassuring. Several studies report good tolerability at doses of 10 to 25 grams per day with long-term use, without serious side effects. Large-scale systematic safety research is still lacking, but no red flags have emerged from the current studies. Collagen injections for rotator cuff tears have been examined only in very small studies with mixed results; no firm conclusions can be drawn on that front yet.
Joint claims: 1 meta-analysis (11 RCTs, 870 participants), 1 systematic review (15 RCTs), and 2 individual double-blind RCTs. Skin claims: narrative review by authors with a commercial interest. Mechanistic distinction native vs. hydrolysed: review with conflict of interest. Safety: multiple studies, limited large-scale systematic research.